An 84-year-old man left clinicians at a Hong Kong hospital utterly perplexed after arriving at the hospital to be treated […] ...
Argyria is caused by a buildup of silver in the body, which discolors the skin.
Managing the unpredictable symptoms of indolent systemic mastocytosis prompted a search for answers and community.
Epidermolysis Bullosa (EB), or butterfly disease, affects 1 in 50,000 people, causing fragile skin that blisters easily, ...
Arctic therapeutics raises funding from EIC Fund, Kaldbakur, and Sanos Group to advance its dementia treatment, AT-001, and acne drug, AT-004. The company aims to transform the treatment landscape for ...
Researchers find that allergy medicine could help patients with a rare genetic disease avoid liver transplants.
Sanofi and Regeneron's Dupixent has become the first biologic drug to show activity in prurigo nodularis (PN), raising the hope of a new treatment option for the rare and highly debilitating skin ...
A common antihistamine may offer hope for patients with a rare genetic disease that can lead to severe liver damage and ...
Skinvisible granted Quoin an exclusive, royalty-bearing license to its technology for use in select rare skin diseases and for the right to use its proprietary formula for Netherton Syndrome.